XML 63 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
GENERAL (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 12 Months Ended 1 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2013
United Therapeutics Corporation [Member]
Jun. 30, 2013
United Therapeutics Corporation [Member]
Licensing Agreements [Member]
GENERAL [Abstract]          
Accumulated losses $ (86,902) $ (65,747) $ (50,953)    
Net loss (21,155) (14,794) (10,848)    
Acquired Finite-Lived Intangible Assets [Line Items]          
Advance payment for development costs         2,000
Contingent consideration receivable if certain regulatory milestones are reached         37,500
Shares to be issued to CHA in exchange for CHA shares       $ 10,000  
Shares to be issued to CHA in exchange for CHA shares, shares       2,500,000  
Shares of CHA common stock to be received, shares       1,011,504